Bioscience

Ventria's Optiferrin shown functionally comparable to human transferrin in published study

Ventria's Optiferrin shown functionally comparable to human transferrin in published study

FORT COLLINS - Ventria Bioscience's Optiferrin recombinant human transferrin has been shown functionally comparable to purified human transferrin in a study just published by the journal BMC... Read More

By: Steve Friday December 14, 2012 0 comments Tags: Dr. Ning Huang, Dr. Wei-Chiang Shen, ExpressTec, Fort Collins, InVitria, Optiferrin, Ventria Bioscience

AspenBio Pharma changes its name to Venaxis

AspenBio Pharma changes its name to Venaxis

CASTLE ROCK - Venaxis Inc. (Nasdaq: APPY) - formerly AspenBio Pharma - has changed its corporate name after a recent meeting of its shareholders, the company announced. The company's... Read More

By: Steve Friday December 14, 2012 0 comments Tags: AspenBio Pharma, Castle Rock, Steve Lundy, Venaxis

Colibri announces successful clinical use of first ready-to-use transcatheter heart valve

Colibri announces successful clinical use of first ready-to-use transcatheter heart valve

BROOMFIELD - Colibri Heart Valve LLC has successfully completed the first clinical use of its proprietary transcatheter aortic heart valve, the company announced. The transcatheter aortic... Read More

By: Steve Thursday December 13, 2012 0 comments Tags: Broomfield, Colibri, Colibri Heart Valve, Joseph B. Horn, TAVI

Cerapedics secures $19M in equity financing to advance bone graft R&D

Cerapedics secures $19M in equity financing to advance bone graft R&D

WESTMINSTER - Cerapedics Inc. today announced it has completed a Series C round of private equity financing totaling $19 million. The new round was led by new investors Medimmune Ventures... Read More

By: Steve Wednesday December 12, 2012 0 comments Tags: Cerapedics, CVF LLC, i-FACTOR, Medimmune Ventures, NGN Capital, OrbiMed Advisors, osteobiologics, Paul Mraz, Sam Wu, Westminster

CU-led team will use $9.2M DOE grant to modify E.coli bacteria into biofuels

CU-led team will use $9.2M DOE grant to modify E.coli bacteria into biofuels

BOULDER - A team led by the University of Colorado Boulder has been awarded $9.2 million over the next five years from the U.S. Department of Energy to research modifying E.coli to... Read More

By: Steve Tuesday December 11, 2012 0 comments Tags: Adam Arkin, biofuels, Boulder, DOE, E-coli, NREL, Pin-Ching Maness, Rob Knight, Ryan Gill

Colorado BioScience Association honors industry's best, TOLMAR named company of year

Colorado BioScience Association honors industry's best, TOLMAR named company of year

DENVER - The Colorado BioScience Association unveiled the 2012 winners of industry awards Thursday at its Annual Awards Dinner, with TOLMAR of Fort Collins taking the Company of the Year... Read More

By: Steve Friday December 7, 2012 0 comments Tags: April Giles, Aurora, Bal Seal Engineering, CBSA, Covidien, Denver, Dorsey and Whitney, Highlands Ranch, Mark Spiecker, Myogen, Rockies Venture Club, Sheridan Ross, Sophono, TOLMAR, William Freytag, Windsor

CSU receives $1M to study rice bran's ability to fight off gut pathogens

CSU receives $1M to study rice bran's ability to fight off gut pathogens

FORT COLLINS - A Colorado State University researcher will receive a $1 million grant from the Bill and Melinda Gates Foundation to study rice bran's ability to fight off multiple gut... Read More

By: Steve Wednesday December 5, 2012 0 comments Tags: Elizabeth Ryan, Fort Collins, rice bran

Ventria Bioscience acquires Meristem Therapeutics' Recombinant Lactoferrin IP

Ventria Bioscience acquires Meristem Therapeutics' Recombinant Lactoferrin IP

FORT COLLINS - Ventria Bioscience will wholly acquire portions of the intellectual property portfolio relating to Recombinant Lactoferrin developed by the French biotech company Meristem... Read More

By: Steve Tuesday December 4, 2012 0 comments Tags: ExpressTec, Fort Collins, Scott Deeter, VEN100, Ventria Bioscience